Previous studies have demonstrated that low CD4 + /CD8 + ratio is a crucial indicator of the severity and poor prognosis of malignant tumors, with a lower ratio indicating a higher risk of tumor metastasis and recurrence31. The gene discussed is CD4; the disease is cancer.